Tissue and cell therapies in the twenty-first century
Author(s) or editor(s)
This exciting new book examines how human tissues and cells are being exchanged, commodified and commercialised by new health technologies. Through a discussion of emergent global ‘tissue economies’ the author explores the social dynamics of innovation in the fields of tissue engineering and stem cell science. A central concern of the book is to consider how regenerative medicine configures and conceptualises bodies. The book argues that the development of regenerative medicine is a feminist issue. It critically examines the transformative potential of regenerative medicine and contests the claim that regenerative medicine represents a paradigm shift from more traditional forms of biomedicine. By developing a feminist analysis of the global bioeconomy the book argues that the users of these technologies are gendered and that women and women’s bodies are enrolled in the production of them in particular ways. This leads to a consideration of how regenerative bodies are theorised and the value of a feminist bioethics for thinking about the ethical issues at stake. Drawing on extensive qualitative field research the issues around donation, procurement, banking and engineering of human tissues are examined and an analysis presented of the regulatory and policy debates within Europe and the UK surrounding these practices. The book concludes with a consideration of the claims made that regenerative medicine represents exciting possibilities for treating the diseases of ageing bodies and a critical assessment of what kind of futures are embodied in tissue and cell based therapies.
Genetics and Society book series – in association with Routledge
The Genetics and Society book series is published in association with Routledge. Please see the appropriate section of their website for further details.